EFPIA Newsletter 02 February 2017

2 February 2017

Highlight of the week View more images The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

News View more images     06 October 2016 EFPIA Statement on the ENVI Committee’s Draft Report on EU Options for Improving Access to... Read more →

Events calendar View more images     28 MAR 2017   DIA BioVenture Day Glasgow, UK Is the current Bioventure paradigm delivering return for patients and investors?" is the key question to be addressed... Learn more →       29 MAR 2017   DIA EuroMeeting 2017 Glasgow, UK DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide... Learn more →

	21 MAY 2017			6th FIP Pharmaceutical Sciences World Congress 2017: Future Medicines For One World... Stockholm, Sweden Future Medicines For One World Learn more →

	06 JUN 2017			170609 Certificate in Healthcare Compliance Ethics & Regulation Paris, France A whole week into the legal framework of healthcare industries Learn more →

What we are reading View more images Press release: CHEM21 method could dramatically cut production costs of essential anti-fungal... 02 February 2017  (IMI) Read more → Health Programme - Annual work plan for 2017 02 February 2017  (European Commission) Read more →

Images View more images

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe